NCT06886191View on ClinicalTrials.gov

PuO2 in RenalGuard Pilot Study

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 17, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Cardiac Surgery Subjects
Interventions
DEVICE

RenalGuard Therapy

Fluid management system, which weighs urine and controls intravenous administration of crystalloid solution.

All Listed Sponsors
lead

Sahlgrenska University Hospital

OTHER

NCT06886191 - PuO2 in RenalGuard Pilot Study | Biotech Hunter | Biotech Hunter